Time to evaluate focal therapy

Smith and colleagues’ findings on quality of life after diagnosis and treatment of localised prostate cancer1 are neither new nor unexpected.2 3 While much resource has gone into refining both radiotherapeutic and surgical approaches to care, the key question is: has increased specification decreased the toxicity of prostate cancer …